With the recent deluge of swine flu and whiny job search posts here, let’s switch gears for a moment.
Remember all the press about Singulair, moodiness, depression, and suicide a year or so ago? Now the FDA has announced Singulair and the other leukotriene modifiers (Accolate, Zyflo) will contain a precaution about these neuropsychiatric symptoms.
Does this mean the FDA found evidence of a link between the medicine and suicidal thoughts in its review?
Not really. But:
In the clinical trial data submitted by manufacturers, neuropsychiatric events were not commonly observed, the FDA said. However, according to the agency, the available data were limited because the trials were not designed to look for neuropsychiatric events. – NewsInferno.com
For asthma parents, this news doesn’t really change anything. As usual, if you have any questions about your kid’s medication you should A) talk to your pediatrician and/or specialist and B) carefully observe your child for any side effects whenever she starts taking a new prescription.
Maybe that’s why I’m so weird…and I thought it was just the steroids;-)